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Abstract
Objective—Saturated fatty acids, such as palmitic and stearic acid, cause detrimental effects in
endothelial cells (ECs) and have been suggested to contribute to macrophage accumulation in
adipose tissue and the vascular wall in states of obesity and insulin resistance. Long-chain fatty
acids are believed to require conversion into acyl-CoA derivatives to exert most of their
detrimental effects, a reaction catalyzed by acyl-CoA synthetases (ACSL). The objective of this
study was to investigate the role of ACSL1, an ACSL isoform previously shown to mediate
inflammatory effects in myeloid cells, in regulating EC responses to a saturated fatty acid-rich
environment in vitro and in vivo.
Methods and Results—Saturated fatty acids caused increased inflammatory activation, ER
stress, and apoptosis in mouse microvascular ECs. Forced ACSL1 overexpression exacerbated the
effects of saturated fatty acids on apoptosis and ER stress. However, endothelial ACSL1-
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deficiency did not protect against the effects of saturated fatty acids in vitro, nor did it protect
insulin resistant mice fed a saturated fatty acid-rich diet from macrophage adipose tissue
accumulation or increased aortic adhesion molecule expression.
Conclusion—Endothelial ACSL1 is not required for inflammatory and apoptotic effects of a
saturated fatty acid-rich environment.
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Introduction
The endothelium protects the organism from a number of diseases, including vascular
disease and insulin resistance.1,2 However, diabetes and cardiovascular risk factors cause
changes in the endothelium, leading to endothelial dysfunction. Elevated levels of fatty acids
are generally believed to cause endothelial dysfunction.3 Palmitic acid (16:0) and stearic
acid (18:0) are two common saturated fatty acids that cause endothelial dysfunction in vitro,
including pro-inflammatory signaling and apoptosis.4-6 Increased activation of the ceramide
pathway and toll-like receptor 4 (TLR4) have been implicated in the pro-inflammatory
changes elicited by palmitate.5,7-10 However, the mechanism by which TLR4 is modulated
by saturated fatty acids remains controversial.11 Saturated fatty acids also induce apoptosis
by a pathway that appears to require endoplasmic reticulum (ER) membrane saturation and
subsequent ER stress12 as well as activation of NF-κB signling.13 ER stress induces
apoptosis through activation of the protein kinase JNK in many cells.14 These mechanisms
require conversion of the free saturated fatty acids to their acyl-CoA derivatives.
Long-chain acyl-CoA synthetase (ACSL) isoforms ligate long-chain fatty acids to the CoA
moiety. Conversion of free fatty acids into their acyl-CoA derivatives is required for
channeling of fatty acids into cellular lipid pools and beta-oxidation, and most of the
biological actions of fatty acids in cells.15 Of the five ACSL isoforms expressed in
mammals, ACSL1, ACSL3, ACSL4, and ACSL5 are expressed in endothelial cells (ECs).16
Specific functions of these ACSL isoforms in endothelial cells are unknown.
Forced overexpression of ACSL1 in the heart causes cardiac lipotoxicity and increased
apoptosis,17 whereas ACSL1-deficiency in myeloid cells protects against the inflammatory
effects of diabetes in monocytes and macrophages, as well as diabetes-accelerated
atherosclerosis.18 We therefore hypothesized that ACSL1-dependent acyl-CoA synthesis
mediates the detrimental effects of saturated fatty acids in ECs in vitro and in vivo.
Our findings show that forced overexpression of ACSL1 in ECs indeed exacerbates
saturated fatty acid-induced apoptosis and ER stress. However, endothelial ACSL1-
deficiency does not protect ECs against the pro-inflammatory and pro-apoptotic effects of
saturated fatty acids in vitro, nor does it protect against increased adipose tissue macrophage
accumulation or aortic expression of vascular cell adhesion molecule 1 (Vcam1) in a
saturated fat-fed mouse model of insulin resistance. These findings suggest that when
overexpressed, ACSL1 is sufficient to exacerbate the effects of saturated fatty acids on ER
stress and apoptosis, but that normally, ACSL1 does not contribute in major ways to these
effects of saturated fatty acids, or to inflammatory changes associated with high fat diet-
feeding.
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Generation of conditional ACSL1 endothelial and hematopoietic-deficient mice
Acsl1flox/flox mice were generated as described previously,19 and backcrossed 10
generations into the C57BL/6 background. These mice were then crossed with Tie2-Cre
mice (The Jackson Laboratory, Bar Harbor, ME) on a C57BL/6 background to obtain mice
with endothelial and hematopoietic ACSL1-deficiency. Female breeders were Cre-negative
to avoid germ-line transmission. The resulting Acsl1flox/floxTie2-Cre+ mice were termed
ACSL1 endothelial and hematopoietic-deficient mice (ACSL1E/H−/− mice). Littermate
controls carried the Cre transgene, but were wild-type (WT) for ACSL1 (Acsl1wt/wtTie2-
Cre+). In addition, Acsl1flox/floxTie2-Cre− control mice were used for some experiments.
Insulin resistant obese mouse model
Male ACSL1E/H−/− mice and WT littermate controls (10-12 weeks of age) were fed chow
diet or a diabetogenic diet with added cholesterol (DDC) rich in saturated fatty acids for 20
weeks, as previously described.20-21 Glucose tolerance tests were performed at week 18, as
previously described.21
Isolation and culture of endothelial cells
Mouse microvascular endothelial cells (MMECs) were isolated by a fluorescence-activated
cell sorting method from lungs or hearts22, or by a magnetic bead positive selection method
from hearts using an ICAM-2 antibody, as previously described.23 Most of the experiments
were performed on heart MMECs isolated by the magnetic bead separation method between
passage 3 and 6. Bovine aortic endothelial cells (BAECs) were purchased from Cambrex
Bioscience (Walkersville, MD).
Additional methods are described in the Supplemental Materials.
Results
Palmitate and stearate promote inflammatory changes and apoptosis in mouse
microvascular endothelial cells
MMECs exposed to palmitate (16:0) or stearate (18:0) bound to BSA at indicated molar
ratios for 24 h exhibited dose-dependent increases in secretion of the chemokines CCL2
(chemokine [C-C motif] ligand 2) and CXCL1 (chemokine [C-X-C motif] ligand 1), as well
as increased shedding of soluble vascular cell adhesion molecule 1 (sVCAM-1) and soluble
intracellular adhesion molecule 1 (sICAM-1), as shown in Figures 1A-D. Significant effects
of 16:0 were observed at 1:2 and 1:3 BSA:fatty acid molar ratios, corresponding to 156
μmol/L and 234 μ 16:0, respectively, whereas 18:0 was more potent and induced significant
changes at 1:0.5 to 1:1 BSA:fatty acid molar ratios, corresponding to 39 μmol/L and 78
μmol/L, respectively. These concentrations of 18:0 are in the physiological range for human
plasma.24 Stearate and palmitate also induced increased caspase 3 activity in these MMECs
(Figure 1E) and apoptosis (Figure 1F). Again, stearate was more potent than palmitate
(Figure 1F). Thus, saturated fatty acids, and particularly stearate, induce an inflammatory
response and apoptosis in MMECs, consistent with studies on ECs from other vascular beds
and species.13,25-26
Li et al. Page 3










Forced overexpression of ACSL1 results in increased palmitoyl-CoA and stearoyl-CoA
levels and exacerbated apoptosis, ER stress and JNK activation in palmitate-stimulated
bovine aortic endothelial cells
The pro-inflammatory and pro-apoptotic effects of saturated fatty acids are likely to be
mediated by the acyl-CoA derivatives of these fatty acids, as discussed above. To investigate
the effect of ACSL1 on saturated fatty acid-induced changes in ECs, we next stably
overexpressed ACSL1 by using a retroviral vector in BAECs. BAECs were used for these
experiments because of their greater proliferative capacity compared to MMECs. Both 16:0
and 18:0 increased chemokine (Ccl2) expression and cell death in these cells, like in
MMECs, whereas oleate (18:1) prevented these effects (Figure S1A-B). The pro-
inflammatory and pro-apoptotic effects of 16:0 were also prevented by triacsin C, an acyl-
CoA synthetase inhibitor that inhibits most ACSL isoforms, consistent with previous
studies13,26 (Figure S1C-E). BAECs infected with the ACSL1 retroviral vector exhibited
clearly detectable myc-tagged ACSL1 protein compared to the empty vector (pBM)-infected
controls (Figure 2A). Consistent with these observations, cell extracts from BAECs
overexpressing ACSL1 exhibited a significant increase in palmitoyl-CoA synthesis (Figure
2B). Whereas there were no significant differences in acyl-CoA levels between ACSL1-
overexpressing cells and controls under basal low-serum conditions, both palmitoyl-CoA
and stearoyl-CoA levels increased in palmitate-stimulated cells overexpressing ACSL1
(Figure 2C). Forced ACSL1 overexpression exacerbated palmitate-induced BAEC cell death
and caspase 3 activity (Figures 2D-E). Saturated fatty acids can promote JNK activation,
thereby inducing apoptosis and pro-inflammatory changes in different cell types.27 To
investigate if ACSL1 overexpression exacerbates the effects of 16:0 on JNK activation,
BAECs were stimulated with 16:0 for 4 h. Cells stimulated with 16:0 demonstrated an
increased JNK phosphorylation, and ACSL1 overexpression further increased 16:0-induced
JNK phosphorylation (Figures 2F-G).
ER stress is often linked to JNK activation.28-29 Therefore, Hspa5 (Grp78) mRNA, an ER
stress marker, was used to evaluate ER stress in control and ACSL1-overexpressing BAECs.
Consistent with the JNK activation, Hspa5 mRNA levels were increased by palmitate-
stimulation, and overexpression of ACSL1 resulted in a further elevation of Hspa5 mRNA
levels (Figure 2H). Increased ER stress has been shown to be associated with an increased
presence of saturated fatty acids in the membrane, and consistently, palmitate-stimulated
BAECs exhibited a marked increase in membrane palmitate levels, which was exacerbated
by ACSL1 overexpression (Figure 2I). Thus, ACSL1 overexpression results in membrane
fatty acid saturation following palmitate-stimulation and accompanied ER stress, JNK
activation, and increased apoptosis.
In order to investigate whether the increased JNK activation contributes to apoptosis in
palmitate-stimulated BAECs, we used the cell-permeable JNK Inhibitor I (EMD Millipore).
As shown by figure 2J, the JNK inhibitor partly but significantly protected palmitate-
stimulated BAECs as well as ACSL1-overexpressing BAECs from apoptosis, as measured
by reduced DNA fragmentation (TUNEL). Similar results were obtained using an unrelated
JNK inhibitor (SP600125, Biomol; data not shown), suggesting that activation of the JNK
pathway is in part responsible for the increased apoptosis in palmitate stimulated BAECs
and BAECs overexpressing ACSL1.
Finally, overexpression of ACSL1 did not significantly alter oxygen consumption,
suggesting that the metabolic state of the ECs was not markedly different depending on
ACSL1 levels (Figure 2K).
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Endothelial ACSL1-deficiency does not provide protection from saturated fatty acid-
induced pro-apoptotic or pro-inflammatory changes
To investigate if intrinsic ACSL1 promotes pro-apoptotic and pro-inflammatory changes in
saturated fatty acid exposed ECs, we next generated mice with endothelium and
hematopoietic-targeted ACSL1-deficiency. Acsl1flox/floxTie2-CreTg (ACSL1E/H−/−) mice
and control littermate WT controls (Acsl1wt/wtTie2-CreTg) were genotyped (Figure 3A) and
used for experiments. Relative Acsl1 mRNA levels were lower in heart MMECs than in
heart tissue (Figure S2). Acsl1 mRNA levels were reduced by 60-75% in freshly isolated
and early passage heart MMECs from ACSL1E/H−/− mice compared to littermate controls
(Figure 3B), while mRNA levels of other ACSL isoforms was unchanged (Figure 3B).
Furthermore, there was no detectable reduction of Acsl1 mRNA levels in livers from
ACSL1EH−/− mice, demonstrating selective loss of ACSL1 (Figure 3B). ACSL1 protein was
also reduced in MMECs from ACSL1EH−/− mice (Figure 3C).
As a second approach, ACSL1 expression was knocked down by siRNA. Acsl1 siRNA
reduced Acsl1 mRNA levels by 80-90% in MMECs, both under basal and fatty acid-
stimulated conditions (Figure 3D). ACSL1 protein levels were also reduced, whereas no
significant compensatory upregulation was found for ACSL3 or ACSL4 protein (Figure 3E).
However, fatty acid stimulation, and especially stearate, upregulated Acsl3 and Acsl4
mRNA levels in MMECs (Figure 3F), suggesting that these ACSL isoforms might take on a
more important role in saturated fatty acid-stimulated MMECs. No compensatory
upregulation of Acsl3, Acsl4 or Acsl5 was observed in MMECs treated with Acsl1 siRNA
under basal or fatty acid stimulated conditions (Figure 3F).
We next investigated fatty acid and glucose utilization in MMECs deficient in ACSL1.
ACSL1 knockdown did not result in a measurable reduction in palmitate beta-oxidation
(Figure S3A), no differences in glucose consumption and a very slight increase in lactate
production (Figures S3B-C). These experiments also demonstrated that these MMECs are
highly glycolytic cells.
Cultured MMECs from WT and ACSL1E/H−/− mice responded to saturated fatty acid
stimulation with an increased secretion of CCL2 (data not shown), and increased shedding
of sVCAM-1 and sICAM-1 (Figures 4A-B). ACSL1-deficiency did not protect against these
effects, but rather tended to exacerbate the stearate-induced effects. Furthermore, palmitate
and stearate induced ER stress, as measured by increased Hspa5 (Grp78) and Ddit3 (Chop)
mRNA levels and Xbp1 splicing (Figures 4C-D and Figure S4). ACSL1-deficiency did not
protect the cells from the stearate- or palmitate-induced ER stress response, but rather
increased levels of the chaperone Hspa5 (Figure 4C). ACSL1-deficiency also did not protect
against saturated fatty acid-induced apoptosis, measured as DNA fragmentation (Figure 4E).
The lack of effects of ACSL1-deficiency was confirmed in MMECs in which ACSL1 had
been downregulated by siRNA. Consistent with the results on MMECs from ACSL1E/H−/−
mice, Acsl1 siRNA did not result in an inhibition of stearate-induced sVCAM-1 or
sICAM-1 shedding, ER stress response genes or apoptosis, but rather an increase in was
observed (Figures 4F-J). Thus, ACSL1 is not required for saturated fatty acid-induced pro-
inflammatory and pro-apoptotic effects in cultured MMECs.
Saturated fatty acids have been shown to mediate inflammatory effects through TLR4 in
endothelial cells,5 and we therefore repeated some of these experiments in MMECs isolated
from hearts of Tlr4+/+ and Tlr4−/− mice. In agreement with previous findings, TLR4-
deficiency exerted a protective effect on stearate-induced CCL2 secretion and sVCAM-1
and sICAM-1 shedding (Figures 5A-C), whereas it did not significantly protect against
saturated fatty acid-induced apoptosis (Figure 5D). Thus, in contrast to ACSL1-deficiency,
TLR4-deficiency blunts the inflammatory effects of stearate. The effects of palmitate were
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weaker than those of stearate, and were not affected by TLR4-deficiency. It is possible that
palmitate mediates its effects in part through other mechanisms, such as through activation
of TLR2.30
Endothelial ACSL1-deficiency does not confer a protective effect in a mouse model of
insulin resistance and dietary fatty acid saturation
Exposure of cells in vitro to single fatty acids bound to BSA can be regarded as a rather
simple and artificial system,31 and we therefore next assessed the potential effects of
endothelial ACSL1-deficiency in vivo. We investigated effects of endothelial ACSL1-
deficiency in a mouse model of insulin resistance and obesity in which mice are fed a diet
with increased fatty acid saturation, sucrose and cholesterol.20-21 Male WT and
ACSL1E/H−/− mice were fed this diabetogenic diet (DDC) or chow for 20 weeks. At the end
of the study, DDC-fed mice were significantly obese, showed increased fasting blood
glucose levels, glucose intolerance, and increased plasma cholesterol levels, as compared to
chow-fed mice (Figures 6A-D). Endothelial ACSL1-deficiency had no effect in chow-fed or
DDC-fed mice on these parameters. Plasma levels of sICAM-1 and sVCAM-1 were not
elevated by the DDC, and were not affected by ACSL1-deficiency (Figures 6E-F), but aortic
levels of Vcam1 mRNA were significantly elevated by DDC-feeding (Figure 6G).
Endothelial ACSL1-deficiency did not protect the aorta from DDC-induced Vcam1
induction (Figure 6G).
Macrophages are known to accumulate in adipose tissue in mice fed high-fat diets, including
the diet used in the present study.20-21 This macrophage accumulation requires monocytes to
bind to and traverse microvessels. We therefore next investigated the effect of DDC and
endothelial ACSL1-deficiency in epididymal fat from chow-fed and DDC-fed mice.
ACSL1E/H−/− mice exhibited no significant differences in the number or morphology of
microvessels in epididymal fat (Figure 6H). As expected, DDC-fed mice had significantly
more macrophages in epididymal fat (measured as increased levels of the myeloid cell/
macrophage markers Emr1 and Cd11b) and increased levels of Ccl2 mRNA (Figures 6I-K)
as compared to chow-fed mice. Endothelial ACSL1-deficiency had no effect on these
parameters (Figures 6I-K). Also, there were no differences in ER stress markers between the
four groups of mice (data not shown).
To evaluate whether the mice had been exposed to elevated saturated fatty acid ratios, fatty
acid composition of the chow diet and DDC as well as plasma fatty acid composition in the
four groups of mice was analyzed by GC-MS. The DDC had higher relative levels of 16:1,
16:0, 18:1 and 18:0, and lower relative levels of 18:2 as compared to the chow diet, and the
ratio of saturated fatty acids/unsaturated fatty acids was significantly higher (Figure 6L).
Plasma levels of fatty acids in the four groups of mice generally reflected the fatty acid
composition of the diet. Thus, mice fed DDC exhibited lower relative levels of 18:2 and
higher relative levels of 18:1 and 18:0 as compared to chow-fed mice (Figure 6M). There
were no differences in 16:0 plasma levels between the different groups. Endothelial ACSL1-
deficiency did not alter plasma fatty acid composition (Figure 6M). Finally, cultured
MMECs were exposed to fatty acid ratios mimicking those found in plasma of chow-fed and
DDC-fed mice. The fatty acids were bound to BSA in a 1:2 BSA:fatty acid ratio. As shown
by Figure 6N, sVCAM-1 shedding was the same in MMECs exposed to fatty acid ratios
mimicking plasma fatty acid ratios in chow-fed mice and DDC-fed mice. Similarly, CCL2
secretion, sICAM-1 shedding and apoptosis were the same in both groups (data not shown).
These studies suggest that endothelial ACSL1-deficiency does not protect mice from a diet
rich in saturated fatty acids on adipose tissue macrophage accumulation or aortic VCAM-1
expression, consistent with the in vitro studies.
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We demonstrate that whereas forced overexpression of ACSL1 in ECs results in
exacerbation of apoptosis, ER stress and JNK activation induced by saturated fatty acids,
ACSL1-deficiency does not protect ECs in vitro or in vivo from the detrimental effects of a
saturated fatty acid-rich environment. Thus, overexpression of ACSL1 is likely to cause
effects that are not normally conferred by ACSL1, perhaps because downstream enzymes
that further process the generated palmitoyl-CoA and stearoyl-CoA are not able to
efficiently deal with the increased acyl-CoA levels. In addition, overexpression of ACSL1 is
likely to result in increased uptake and trapping of saturated fatty acids through vectorial
acylation, especially under in vitro conditions in which only saturated fatty acids are
provided. Consistent with these findings, overexpression of ACSL1 in the heart causes
increased apoptosis and cardiomyopathy,17 and this can be prevented by also overexpressing
diacylglycerol acyltransferase 1 (DGAT1), which promotes downstream triacylglycerol
formation.32 Palmitate has previously been shown to cause ER stress and apoptosis by
increasing ER membrane saturation.12 Our finding that ACSL1 overexpression exacerbates
palmitate-induced apoptosis, ER stress and membrane palmitate accumulation suggests that
ACSL1 has the ability to enhance this pathway in ECs.
ACSL1 normally expressed in ECs is likely to act in different subcellular compartments or
on different fatty acids as compared to overexpressed ACSL1 because endothelial ACSL1-
deficiency did not protect ECs from saturated fatty acid-induced apoptosis, ER stress, or
release of inflammatory mediators, nor did ACSL1E/H−/− mice show a clear phenotype in a
mouse model of insulin resistance associated with saturated fatty acid feeding. Instead, other
ACSL isoforms or other enzymes with acyl-CoA synthetase activity are likely to mediate at
least part of the effects of saturated fatty acids in ECs. This conclusion is based on the lack
of effect of ACSL1-deficiency on saturated fatty acid-mediated effects, and also on the
finding that triacsin C, a pharmacologic general ACSL inhibitor, prevents saturated fatty
acid-induced apoptosis13,26, indicating that a triacsin C-inhibitable enzyme(s) is in part
responsible for the saturated fatty acid effects in ECs, consistent with results from the
present study, which demonstrated that triacsin C prevents the pro-inflammatory and pro-
apoptotic effects of palmitate in BAECs. ACSL1 acts on a broad range of fatty acids, but is
not specific to saturated fatty acids. For example, in hepatocytes oleoyl-CoA levels are most
reduced by ACSL1-deficiecy,19 whereas in thioglycollate-elicited macrophages
arachidonoyl-CoA levels are preferentially reduced by ACSL1-deficiency.18 Since ECs do
not express significant levels of ACSL6, it is possible that the effects of palmitate and
stearate are mediated by ACSL4, ACSL3 and/or ACSL5 in ECs. Consistently, our results
suggest an increase in ACSL3 and ACSL4 expression in fatty acid-stimulated ECs.
However, part of the effect of saturated fatty acids on release if inflammatory markers and
apoptosis might be mediated by the free fatty acids, for example by altering membrane
biophysical properties. The tendency of ACSL1-deficiency to exacerbate the effects of
stearate supports this interpretation. Contrary to ACSL1-deficiency, TLR4-deficiency
conferred protective effects against the inflammatory effects of stearate, consistent with
published studies.5 Thus, ACSL1-deficiency and TLR4-deficiency exert the opposite effects
in stearate-stimulated ECs.
Rather than mediating effects of saturated fatty acids, ACSL1 appears to have other
biological functions in ECs. ACSL1 has a prominent role in mediating beta-oxidation in
many tissues depending on fatty acids as an energy source, such as heart, liver, and adipose
tissue.19,33-34 Conversely, we have recently demonstrated that in macrophages, ACSL1 does
not contribute to beta-oxidation, but has a prominent role in mediating inflammatory
changes in response to diabetes, most likely by acting on arachidonic acid.18 ACSL1 also
does not appear to contribute to beta-oxidation in endothelial cells, at least not under the
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conditions tested. Overall, these studies support the hypothesis that ACSL isoforms may
have distinct biological functions that are context- and cell type-dependent, and perhaps
dependent on the availability of different fatty acid substrates under different conditions as
well as the metabolism of the cell. The current work is the first study to investigate the
biological role of any of the ACSL isoforms in endothelial cells in vivo. Future studies on
endothelial ACSL1 include its potential role in atherosclerosis, vasoreactivity and blood
pressure regulation, as well as evaluation of potential effects of ACSL1 on eNOS activity.
The study also raises more complex questions. For example, to what extent do plasma levels
of saturated fatty acids contribute to inflammatory reactions in vivo? Ratios of fatty acids
mimicking those found in plasma of mice fed the high fat diet used in the present study did
not promote inflammatory changes or apoptosis, as compared to ratios of fatty acids
reflecting plasma levels in chow fed mice. It is possible that the inflammatory effects of
diets rich in saturated fatty acids are due to associated systemic factors, such as
cholesterol,20 or to increased tissue levels of saturated fatty acids or acyl-CoAs. In this
context, it is interesting to speculate that upregulation of ACSL1 or other ACSL isoforms
under inflammatory conditions18 might lead to increased trapping of fatty acids as acyl-
CoAs in tissues regardless of plasma fatty acid levels.
In conclusion, this study shows that although overexpressed ACSL1 can act to exacerbate
detrimental effects of saturated fatty acids in ECs, normally, ACSL1 does not mediate the
inflammatory or apoptotic effects of a saturated fatty acid-rich environment.
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Figure 1. Saturated fatty acids exhibit pro-inflammatory and pro-apoptotic effects in mouse
endothelial cells
A-D, Heart MMECs (passage 3) were stimulated with 16:0 or 18:0 bound to BSA at
indicated BSA:fatty acid molar ratios in the presence of 1% FBS for 24 h. The BSA
concentration was 78 μmol/L. CCL2 secretion (A), CXCL1 secretion (B), sVCAM-1 (C)
and sICAM-1 (D) shedding were analyzed by ELISAs. Caspase 3 activity was measured by
a fluorometric assay in heart MMECs stimulated with 156 μmol/L 16:0 or 18:0 bound to
BSA at a 1:2 molar ratio for 24 (E). Apoptosis was measured as DNA fragmentation
(TUNEL) using the HT TiterTACSTM assay kit (F). N=3-6; mean ±SEM
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Figure 2. ACSL1 overexpression exacerbates effects of palmitate in bovine aortic endothelial
cells
BAECs were transduced with the empty pBM vector, a vector encoding ACSL1-myc, or no
vector (control). A, Cell lysates (45 μg/lane) were separated on SDS-PAGE gels. Blots were
probed with anti-myc and anti-β-actin antibodies. B, ACSL activity was analyzed in cell
lysates as the rate of conversion of [3H]-16:0 to [3H]-palmitoyl-CoA. C, BAECs were
treated with or without 156 μmol/L 16:0 bound to BSA at a 1:2 BSA:fatty acid ratio for 24
h. Acyl-CoA species were quantified by LC-ESI-MS/MS. D, BAECs overexpressing
ACSL1 were treated with 16:0 for 2 days, and cell death was determined as the percentage
of floating propidium iodide-positive cells. E, Caspase 3 activity was measured after 16:0
treatment for 24 h. F,G, Cells infected with pBM or ACSL1 were stimulated with 16:0 for 4
h. Total cell lysates (40 μg/lane) were separated on 12% SDS-PAGE gels. Blots were
probed with anti-phospho-JNK and anti-JNK antibodies. H, Hspa5 mRNA was measured by
real-time PCR after 24 h stimulation. I, Membrane fatty acid composition of BAECs was
analyzed by GC-MS following a 24 h stimulation with 16:0 and expressed as % of total fatty
acids analyzed. J, Apoptosis was detected using the HT TiterTACSTM assay in BAECs
incubated in the presence or absence of a cell-permeable JNK inhibitor I (JNK I; 10 μmol/
L). K, Oxygen consumption was measured in real time. Data represents the steady state
values of kinetic data, after normalizing to the value obtained at 5 mmol/L glucose without
palmitate (the oxygen consumption rate at 5 mmol/L glucose was 1.26 ± 0.35 nmol/min/105
cells for control BAECs, and 0.69 ± 0.28 for BAECs overexpressing ACSL1). N=3-6; mean
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±SEM; white bars, control cells; gray bars, ACSL1- overexpressing cells infected with the
empty pBM vector
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Figure 3. ACSL1-deficiency in MMECs induced by Tie2-Cre or siRNA
A, PCR amplification of Acsl1 LoxP sites and Tie2-Cre recombinase. B, Levels of Acsl
mRNA in heart MMECs and liver from ACSL1E/H−/− mice and wildtype (WT) littermates
were measured by real-time qPCR. C, ACSL1 protein levels in lung MMECs from
ACSL1E/H−/− mice and wildtype (WT) littermates. ACSL1 runs above a prominent non-
specific band in MMECs. D, Acsl1 mRNA levels in heart MMECs treated with Acsl1
siRNA or control siRNA and then stimulated with 16:0 or 18:0 at a BSA:fatty acid ratio of
1:3 for 24 h. E, ACSL1, ACSL3 and ACSL4 protein levels in heart MMECs grown in 10%
serum. Quantification of ACSL1 and ACSL3 protein levels (N=3) is shown below the
representative blots. F, Acsl3, Acsl4 and Acsl5 mRNA levels in the samples analyzed in D.
N=3-5; mean±SEM; white bars, WT MMECs (B) or MMECs expressing control siRNA (D-
F); gray bars, MMECs from ACSL1E/H−/− mice (B) or MMECs expressing Acsl1 siRNA
(D-F)
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Figure 4. ACSL1-deficient MMECs are not protected from the pro-inflammatory or pro-
apoptotic effects of saturated fatty acids
sVCAM-1 and sICAM-1 shedding was measured by ELISA after a 24 h stimulation with
16:0 or 18:0 at a 1:2 BSA:fatty acid molar ratio in MMECs from ACSL1E/H−/− and WT
mice (A-B) or heart MMECs treated with Acsl1 siRNA or control siRNA (F-G). The ER
stress markers Hspa5 and Ddit3 were measured by real-time PCR in MMECs from
ACSL1E/H−/− and WT mice (C-D) or MMECs treated with Acsl1 siRNA or control siRNA
(H-I). Apoptosis was detected using the HT TiterTACSTM assay in MMECs from
ACSL1E/H−/− and WT mice (E) or MMECs treated with Acsl1 siRNA or control siRNA (J).
The effects of fatty acids were lower (F-J) in electroporated cells, and the palmitate effect
was not significant and therefore not shown. N=3-5; mean±SEM; white bars, WT MMECs
(A-E) or MMECs expressing control siRNA (F-J); gray bars, MMECs from ACSL1E/H−/−
mice (A-E) or MMECs expressing Acsl1 siRNA (F-J)
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Figure 5. TLR4-deficiency exerts protective effects in stearate-stimulated MMECs
A-C, CCL2 secretion, sVCAM-1 shedding and sICAM-1 shedding were measured by
ELISA in conditioned media from Tlr4+/+ or Tlr4−/− heart MMECs (passage 4) incubated in
the presence or absence of 16:0 or 18:0 bound to BSA at a 1:3 molar ratio, or in the presence
of BSA alone for 24 h (Basal). D, Apoptosis was detected using the HT TiterTACSTM
assay. N=3-6; mean ± SEM; white bars, Tlr4+/+ MMECs; black bars, Tlr4−/− MMECs
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Figure 6. Endothelial ACSL1-deficiency does not protect against the effects of obesity and insulin
resistance on adipose tissue macrophage accumulation or aortic VCAM-1 expression
Male WT and ACSL1E/H−/− mice were fed regular chow or DDC for 20 weeks. A, Body
weights at the end of the study. B, Fasting (5 h) blood glucose levels at week 18. C, Glucose
tolerance tests were performed at week 18 by injecting 1.5 g/kg dextrose into 5 h fasted mice
and blood glucose was measured at indicated times. D, Plasma cholesterol levels at the end
of the study. E-F, Plasma sICAM-1 and sVCAM-1 levels at the end of the study. G, Aortae
were harvested in RNA-later (Qiagen, Valencia, CA), and levels of Vcam1 mRNA were
measured by real-time PCR. H, Epididymal fat pads were isolated and sectioned. An anti-
vWF antibody was used to detect ECs in microvessels. Scale bar indicates 20 μm. I-K, The
macrophage markers Emr1 (F4/80) and Cd11b, and Ccl2 mRNA were measured in
epididymal adipose tissue by real-time PCR. L, Fatty acid composition of the chow diet and
DDC was analyzed by GC-MS and was expressed as saturated/unsaturated fatty acid ratio.
M, Fatty acid composition of plasma samples was measured by GC-MS. N, sVCAM-1
secretion was measured by ELISA from MMECs incubated in the presence of fatty acid
ratios reflecting plasma fatty acids in chow-fed and DDC-fed mice. N=5-8 per group; mean
±SEM; white bars, WT mice; gray bars, ACSL1E/H−/− mice
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